WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlexander Rialdi, Arvin C. Dar, Z.M. Khan et al.|Nature Cancer|2023Cited by 27
An Antagonist of KSR1‐Driven Adaptive Resistance to Clinical RAS‐MAPK InhibitorsArthur Chow, Arvin C. Dar, Kyna Reyes et al.|The FASEB Journal|2022Cited by 0